Margo R. Roberts, Chief Scientific Officer at Kite Pharma, Inc. (KITE), sold 6,145 shares at $78.71 ($480K) on 2015-11-16, disclosed to the SEC on 2015-11-18.
Scheduled sale ($480k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.53 | 1,000 | $77K | 15.9% |
| 2 | $78.02 | 2,463 | $192K | 40.0% |
| 3 | $78.71 | 2,237 | $176K | 36.7% |
| 4 | $79.78 | 445 | $36K | 7.4% |
| Total | $78.16 avg | 6,145 | $480K | 100% |
| Filing → |
| KITE | SELL | 2016-02-16 | $1.2M | — | Filing → |
| KITE | SELL | 2016-01-19 | $339K | — | Filing → |
| KITE | SELL | 2015-12-17 | $392K | — | Filing → |